文献速递糖尿病

昼夜光照与静息-活动节律同MASLD风险的关联:两项全国性队列研究启示

Diurnal Light Exposure and Rest-Activity Rhythms in Relation to MASLD: Insights From 2 Nationwide Cohort Studies.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

基于NHANES与UK Biobank加速度计数据,分析24小时光照、静息-活动节律(24-h-RAR)与新发MASLD风险的关系。UK Biobank前瞻性分析显示,相对振幅(RA)每增加0.1单位及最活跃10小时活动水平(M10)每增加1单位,MASLD风险分别降低30%与2%;最不活跃5小时活动水平(L5)每增加1单位及L5起始延迟分别与MASLD风险增加8%与21%相关。日间>6000勒克斯光照每增加1小时与MASLD风险降低9%相关,夜间>30勒克斯光照每增加30分钟与风险增加22%相关,NHANES分析呈相似关联。

要点

  • 较高的日间光照与较低的夜间光照可能降低MASLD风险。
  • 相对振幅较高及M10较高与MASLD风险降低相关。
  • L5较高及L5起始延迟与MASLD风险增加相关。

核心结论

  • 增加日间光照、减少夜间光照及调节静息-活动节律可能预防MASLD及其向肝纤维化和晚期肝病进展。

研究设计与样本

  • 研究使用NHANES与UK Biobank两个队列的加速度计数据,评估24小时光照暴露与静息-活动节律(24-h-RAR)同新发MASLD风险的关联。
  • 24-h-RAR采用非参数指标评估,包括最活跃10小时活动水平(M10)、最不活跃5小时活动水平(L5)、相对振幅(RA)、M10起始及L5起始。
  • 光照暴露分为日间与夜间时段,并按不同阈值水平分别记录暴露时长。
  • 主要结局为MASLD,次要结局包括肝纤维化与肝硬化。

主要发现

  • UK Biobank前瞻性分析中,RA每增加0.1单位与MASLD风险降低30%相关,M10每增加1单位与MASLD风险降低2%相关。
  • L5每增加1单位与MASLD风险增加8%相关,L5起始延迟与MASLD风险增加21%相关。
  • 日间>6000勒克斯光照每增加1小时与MASLD风险降低9%相关,夜间>30勒克斯光照每增加30分钟与MASLD风险增加22%相关。
  • 有利的24-h-RAR特征与充足光照与纤维化、肝硬化风险降低及MASLD患者预期寿命改善相关。
  • NHANES分析中观察到相似关联。

临床怎么用

  • 内分泌科评估MASLD风险时可关注患者昼夜光照模式与静息-活动节律。
  • 建议患者增加日间户外光照、减少夜间光照暴露以降低MASLD风险。
  • 对MASLD患者,改善静息-活动节律可能有助于降低纤维化、肝硬化风险并改善预期寿命。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Circadian rhythms may influence metabolic dysfunction-associated steatotic liver disease (MASLD), but the effect of personal light exposure and rest-activity rhythms on MASLD risk remain unclear. OBJECTIVE: To examine the associations between 24-hour light exposure, rest-activity rhythm (24-h-RAR), and the risk of incident MASLD, as well as how these factors influence genetic risk and life expectancy in individuals with MASLD. METHODS: This study used accelerometry data from both the National Health and Nutrition Examination Survey (NHANES) and UK Biobank cohorts. 24 h-RAR was assessed using nonparametric metrics, including activity level during the most active 10 hours (M10), activity level during the least active 5 hours (L5), relative amplitude (RA), M10 onset, and L5 onset. Light exposure was categorized into daytime and nighttime periods, with exposure durations recorded separately at different threshold levels. The primary outcome was MASLD, with secondary outcomes including fibrosis and cirrhosis. RESULTS: In the UK Biobank prospective analysis, each 0.1-unit and 1-unit increase in RA and M10 were associated with a 30% and 2% reduction of MASLD risk, respectively. In contrast, each 1-unit increase in L5 and delayed L5 onset were linked to an 8% and 21% increase of MASLD risk. Moreover, each additional hour of daylight exposure above 6000 lux was associated with a 9% lower risk of MASLD, while each additional 30 minutes of nocturnal light exposure above 30 lux corresponded to a 22% higher risk of MASLD. Additionally, a favorable 24 h-RAR profile and adequate light exposure were associated with a lower risk of fibrosis and cirrhosis, as well as improved life expectancy among participants with MASLD. Similar associations were observed in the NHANES analysis. CONCLUSION: Greater daytime light exposure, reduced nocturnal light exposure, and regulated RARs may protect against MASLD and prevent its progression to liver fibrosis and advanced liver disease.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wu H, Wang W, Weng B, et al. Diurnal Light Exposure and Rest-Activity Rhythms in Relation to MASLD: Insights From 2 Nationwide Cohort Studies. J Clin Endocrinol Metab. 2026. PMID: 41160717. doi:10.1210/clinem/dgaf593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。